Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 30.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02, Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Offic |
| 03.04.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers, Election of Directors; Appointment of Certain Officers; |
Stammdaten
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.
Unternehmen & Branche
| Name | ENvue Medical, Inc. |
|---|---|
| Ticker | FEED |
| CIK | 0001326706 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Specialties |
| SIC | 3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies |
Wertpapier & Kennzahlen
| CUSIP | 29415F100 |
|---|---|
| ISIN | US29415F1007 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,4 Mio. USD |
| Beta | 2,10 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 2,553,000 | -18,185,000 | -26.69 | 41,124,000 | 33,497,000 |
| 2025-09-30 | 10-Q | 722,000 | 510,000 | -0.91 | 54,383,000 | 42,464,000 |
| 2025-06-30 | 10-Q | 494,000 | -3,971,000 | -1.03 | 51,482,000 | 40,477,000 |
| 2025-03-31 | 10-Q | 1,025,000 | -2,495,000 | 3.98 | 44,105,000 | 35,675,000 |
| 2024-12-31 | 10-K | 2,558,000 | -3,705,000 | -137.30 | 3,629,000 | 627,000 |
| 2024-09-30 | 10-Q | 376,000 | -998,000 | -3.56 | 4,682,000 | 1,872,000 |
| 2024-06-30 | 10-Q | 817,000 | -688,000 | -27.18 | 5,696,000 | 2,841,000 |
| 2024-03-31 | 10-Q | 921,000 | -588,000 | 2.38 | 6,235,000 | 3,504,000 |
| 2023-12-31 | 10-K | 2,283,000 | -3,711,000 | -23.32 | 6,674,000 | 3,989,000 |
| 2023-09-30 | 10-Q | 458,000 | -727,000 | -0.42 | 7,361,000 | 4,690,000 |
| 2023-06-30 | 10-Q | 294,000 | -1,074,000 | -0.65 | 3,831,000 | 1,165,000 |
| 2023-05-22 | 10-Q | 500,000 | ||||
| 2023-03-31 | 10-Q | 354,000 | -1,097,000 | -0.67 | 4,811,000 | 2,203,000 |
| 2022-12-31 | 10-K | 752,000 | -5,448,000 | -3.84 | 5,879,000 | 3,233,000 |
| 2022-09-30 | 10-Q | 97,000 | -955,000 | -0.68 | 5,210,000 | 3,154,000 |
| 2022-06-30 | 10-Q | 485,000 | -1,302,000 | -0.93 | 6,542,000 | 4,134,000 |
| 2022-03-31 | 10-Q | 272,000 | -1,132,000 | 7,663,000 | 5,261,000 | |
| 2021-12-31 | 10-K | 1,695,000 | -14,282,000 | 8,622,000 | 6,313,000 | |
| 2021-09-30 | 10-Q | 499,000 | -6,675,000 | 9,666,000 | 8,711,000 | |
| 2021-06-30 | 10-Q | 318,000 | -216,000 | 6,832,000 | 4,164,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-02-02 | BANK OF AMERICA CORP /DE/ | 10% Owner | Open Market Sale | -2 | 3.05 | -6.10 | 0,0% | |
| 2026-02-02 | BANK OF AMERICA CORP /DE/ | 10% Owner | Open Market Sale | -4 | 3.05 | -12.20 | 0,0% | |
| 2026-02-02 | BANK OF AMERICA CORP /DE/ | 10% Owner | Open Market Sale | -10 | 3.05 | -30.50 | -0,1% | |
| 2026-02-02 | BANK OF AMERICA CORP /DE/ | 10% Owner | Open Market Sale | -18 | 3.05 | -54.90 | -0,1% | |
| 2026-02-02 | BANK OF AMERICA CORP /DE/ | 10% Owner | Open Market Sale | -50 | 3.05 | -152.50 | -0,4% | |
| 2026-02-02 | BANK OF AMERICA CORP /DE/ | 10% Owner | Open Market Sale | -82 | 3.05 | -250.10 | -0,7% | |
| 2026-02-02 | BANK OF AMERICA CORP /DE/ | 10% Owner | Open Market Sale | -90 | 3.05 | -274.50 | -0,7% | |
| 2026-02-02 | BANK OF AMERICA CORP /DE/ | 10% Owner | Open Market Sale | -98 | 3.05 | -298.90 | -0,8% | |
| 2026-02-02 | BANK OF AMERICA CORP /DE/ | 10% Owner | Open Market Sale | -100 | 3.04 | -304.00 | -0,8% | |
| 2026-02-02 | BANK OF AMERICA CORP /DE/ | 10% Owner | Open Market Sale | -100 | 3.05 | -305.00 | -0,8% | |
| 2026-02-02 | BANK OF AMERICA CORP /DE/ | 10% Owner | Open Market Sale | -100 | 3.06 | -306.00 | -0,8% | |
| 2026-02-02 | BANK OF AMERICA CORP /DE/ | 10% Owner | Open Market Sale | -100 | 3.07 | -307.00 | -0,8% | |
| 2026-02-02 | BANK OF AMERICA CORP /DE/ | 10% Owner | Open Market Sale | -183 | 3.05 | -558.15 | -1,5% | |
| 2026-02-02 | BANK OF AMERICA CORP /DE/ | 10% Owner | Open Market Sale | -200 | 3.06 | -612.00 | -1,6% | |
| 2026-02-02 | BANK OF AMERICA CORP /DE/ | 10% Owner | Open Market Sale | -417 | 3.05 | -1,271.85 | -3,3% | |
| 2026-02-02 | BANK OF AMERICA CORP /DE/ | 10% Owner | Open Market Sale | -500 | 3.05 | -1,525.00 | -4,0% | |
| 2026-01-14 | Glibert Christian Michael | 10% Owner | Open Market Purchase | 240,000 | 2.67 | 640,800.00 | +1683,5% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.